Phase 1b safety and immunogenicity study of a universal flu vaccine

Trial Profile

Phase 1b safety and immunogenicity study of a universal flu vaccine

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Feb 2011

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Influenza A virus DNA vaccine-H5N1; Influenza A virus vaccine-H5N1
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Dec 2010 Results to be reported at the World Health Organization 7th Meeting on Evaluation of Pandemic Influenza Prototype Vaccines in Clinical Trials, according to a Dynavax media release.
    • 27 Sep 2010 New trial record
    • 23 Sep 2010 Preliminary data is expected to be available in early 2011, and subjects will continue to be monitored for a further year, according to a Dynavax Technologies media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top